Welcome to our dedicated page for Philip Morris International SEC filings (Ticker: PM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Philip Morris International's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Philip Morris International's regulatory disclosures and financial reporting.
Philip Morris International Inc. director and chairman Andre Calantzopoulos reported a tax-related share disposition. On February 18, 2026, 14,740 shares of common stock were withheld at $182.67 per share to satisfy tax obligations tied to vesting Performance Stock Units, rather than an open‑market sale. Following this transaction, he directly held 587,663 shares of Philip Morris International common stock. An additional 398,412 shares are held indirectly by his spouse, and he disclaims beneficial ownership of those securities.
Philip Morris International Inc. executive Frederic De Wilde, CEO PMI International, reported two stock transactions. He sold 20,000 shares of common stock in an open-market transaction at a weighted average price of $182.58 per share and now holds 133,513 shares, including 39,140 restricted share units. In a separate transaction, 1,000 shares at $182.67 were withheld to cover tax obligations tied to vesting equity awards.
Philip Morris International reported an intended sale of 1,000 shares of Common Stock under Form 144 through UBS Financial Services Inc. The filing lists two vested restricted awards—428 shares (02/16/2022) and 572 shares (02/15/2023)—and shows a planned sale date of 02/20/2026 by wire.
Philip Morris filed a Form 144 reporting proposed sales of Common Stock by a selling holder.
The filing lists vested awards with specific share amounts and grant dates: a Vested Restricted Award of 112 shares (grant 02/15/2023), a Vested Performance Award of 2,333 shares (grant 02/15/2023), a Vested Restricted Award of 2,327 shares (grant 02/21/2024), and a Vested Performance Award of 228 shares (grant 02/21/2024). The filing references 02/20/2026 and lists Common Stock trades via wire.
Philip Morris International filed a Form 144 reporting proposed sales of common stock through UBS Financial Services Inc. on 02/20/2026. The filing lists shares tied to vested awards, including 4,035 and 6,962 share entries as examples. The entries specify vested restricted and vested performance awards as the source of the shares.
Philip Morris International reports proposed sales of vested equity awards under a Form 144. The notice lists multiple vested restricted and performance awards tied to grant dates of 02/15/2023 and 02/21/2024, with examples including 3,227 and 9,436 shares, and a broker listed as UBS Financial Services Inc.
Philip Morris International reports an intended sale of 4,000 shares of Common Stock. The form lists the broker UBS Financial Services Inc and shows settlement/transaction activity on 02/18/2026 and 02/19/2026.
The entries identify two award types that vested on 02/18/2026: a Vested Restricted Award and a Vested Performance Award, with sale movement recorded as Wire through UBS on 02/19/2026.
Philip Morris International Inc. furnished an investor presentation from the CAGNY conference, outlining its strategy to become predominantly smoke-free and its financial targets. Smoke-free products generated $16,854 million of 2025 net revenues, or 41.5% of the total $40,648 million, and contributed an increasing share of gross profit.
The company reported 2025 adjusted net revenues up 7.9% from 2024 on an organic basis and strong operating income growth, with 2020‑2025 adjusted operating income rising from $11,771 million to $16,428 million. Adjusted diluted EPS reached $7.54 in 2025, with currency-neutral growth of 14.2%.
For 2026‑2028, Philip Morris targets a 6‑8% organic net revenue CAGR, 8‑10% operating income organic CAGR, and 9‑11% currency-neutral adjusted diluted EPS CAGR, supported by high single- to low-teens volume growth in smoke-free products. The company expects about $45 billion of operating cash flow over 2026‑2028 and emphasizes ongoing dividend growth and deleveraging toward roughly 2.0x net debt to adjusted EBITDA.